Public Profile

Janssen

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is a leading player in the global pharmaceutical industry, headquartered in the United States. Founded in 1953, the company has made significant strides in various therapeutic areas, including oncology, immunology, neuroscience, and infectious diseases. With a commitment to innovation, Janssen is renowned for its core products, such as innovative treatments for cancer and autoimmune disorders, which are distinguished by their efficacy and safety profiles. The company has achieved notable milestones, including the development of groundbreaking therapies that have transformed patient care. Janssen's strong market position is underscored by its extensive research and development efforts, which continue to drive advancements in medicine, making it a trusted name in healthcare worldwide.

DitchCarbon Score

How does Janssen's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Janssen's score of 3 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.

15%

Janssen's reported carbon emissions

Janssen, headquartered in the US, currently does not provide specific carbon emissions data for the most recent year, nor do they outline any formal reduction targets or initiatives. Without available figures, it is challenging to assess their current carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the absence of detailed emissions data and reduction commitments suggests a need for greater transparency in their climate strategy. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Janssen to establish clear climate commitments and measurable targets to align with global efforts to combat climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Janssen's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Janssen is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Janssen is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

American Homepatient Of Illinois, Inc.

US
Health Services
Updated 3 days ago
UN

South Pole

CH
Health Services
Updated 10 days ago

R&J Industry

HK
Health Services
Updated 9 days ago

LIGHTMED

US
Health Services
Updated 10 days ago

Pharmaghreb

TN
Health Services
Updated 10 days ago

Xikang Health Technology Co., Ltd

CN
Health Services
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers